| Breakdown | Mar 2026 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.62B | 2.15B | 1.95B | 1.82B | 1.81B |
| Gross Profit | 1.27B | 2.00B | 1.66B | 754.10M | 874.30M |
| EBITDA | 1.59B | 1.19B | 992.70M | 1.18B | 1.16B |
| Net Income | 586.80M | 264.70M | 126.90M | 204.90M | 453.40M |
Balance Sheet | |||||
| Total Assets | 18.13B | 16.77B | 15.65B | 14.53B | 14.18B |
| Cash, Cash Equivalents and Short-Term Investments | 1.79B | 1.67B | 1.40B | 340.40M | 744.10M |
| Total Debt | 11.49B | 10.79B | 10.00B | 8.44B | 8.45B |
| Total Liabilities | 15.89B | 14.77B | 13.60B | 12.02B | 11.15B |
| Stockholders Equity | 2.24B | 2.00B | 2.06B | 2.51B | 3.03B |
Cash Flow | |||||
| Free Cash Flow | -110.20M | -79.90M | -19.00M | 93.50M | 221.80M |
| Operating Cash Flow | 1.38B | 918.10M | 745.10M | 787.50M | 865.80M |
| Investing Cash Flow | -1.48B | -987.20M | -731.40M | -593.40M | -555.70M |
| Financing Cash Flow | 221.40M | 358.80M | 1.04B | -85.00M | -89.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | £2.47B | 56.11 | 3.09% | 6.56% | 19.50% | ― | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
62 Neutral | £60.85B | 18.35 | 8.47% | 4.15% | -3.76% | 8.19% | |
59 Neutral | £28.99B | 23.26 | 7.09% | 2.98% | 0.54% | -5.54% | |
59 Neutral | £8.68B | 40.40 | 1.68% | 2.86% | -2.11% | -104.48% | |
58 Neutral | £10.01B | 15.62 | 27.72% | 4.45% | 21.96% | 121.69% | |
55 Neutral | £9.04B | 24.11 | 20.35% | 4.50% | 16.66% | 61.14% |